ITGAX and Hepatic fibrosis: It has been reported that DCs exhibit fibrolytic properties, and the depletion of CD11c+ cells in the CCl4–induced liver fibrosis model led to slower fibrosis regression and reduced clearance of activated hepatic stellate cells.